Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

2(50.0%)

Phase 2

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 1(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03681912Completed

Tailored Motivational Interviewing Implementation-Effectiveness Trial in Multidisciplinary Adolescent HIV Care Settings

Role: collaborator

NCT06029530Phase 1Withdrawn

Delaying the Onset of Nearsightedness Until Treatment Study

Role: collaborator

NCT00004494Phase 1Completed

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

Role: collaborator

NCT00014742Phase 3Completed

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

Role: lead

NCT00004409Phase 2Completed

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

Role: lead

NCT00260806Completed

Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children

Role: collaborator

All 6 trials loaded